Bryn Williams-Jones, a well-known commercial life sciences researcher, has made significant contributions to the field by conducting experiments at Pfizer Global R&D and leading innovative initiatives. He has also been associated with the Open PHACTS Foundation as CEO and Connected Discovery Ltd as Founder and Chief Operating Officer, successfully implementing knowledge solutions for drug discovery by connecting companies, specialists, and leading academics. With his experience in pre-competitive solutions to knowledge-based challenges facing drug discovery, Bryn is currently serving as the VP of Drug Discovery at BenevolentAI. He has been a regular contributor to publications like Nature Reviews Drug Discovery, highlighting the significance of informatics in generating actionable knowledge. His technical consulting and software production capabilities make ConnectedDiscovery a reliable partner in making impactful projects work. Bryn completed his BSc (Hons) at Liverpool John Moores University.